AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Cellmark Goes to Orchid.(Brief Article)
Orchid BioSciences, Inc. (Princeton, NJ 08540; Tel: 609/750-2200; Website: www.snps.com) has acquired all assets of the AstraZeneca (15 Stanhope Gate, London W1Y 6LN, Tel: 171-304-5000, Fax: 171- 304-5151, Website: www.astrazeneca.com) subsidiary Cellmark Diagnostics, a provider of genetic diversity testing services in the U.K. Cellmark was one of the world's first commercial DNA testing laboratories and pioneered the introduction of DNA testing for paternity and forensics analyses in the U.K.
"Orchid is committed to rapidly expanding our presence in Europe, and Cellmark provides an ideal base enabling us to accelerate this process," says Dale Pfost, chairman, …
